Charles Ternent, MD
Colon & Rectal Surgery · Omaha, NENPI 1841289147
Payments from drug & device makers
What this record shows
This record is dominated by education: $4,000 of the $6,632 with a category attached, or 60.3%. Intuitive Surgical accounts for 74.0% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $3,710 and has fallen 85.1% since, to $554 in 2025.
Across 52 payments — averaging $127.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Davol Inc.$618
- TELA Bio, Inc.$303
- Virtual Incision Corporation$154
- Johnson & Johnson$84
- Mallinckrodt Enterprises LLC$73
- plus $490 from 15 others
Across 8 payments — averaging $4543.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$18K
- BD$11K
- Cosette Pharmaceuticals Inc.$6K
- Davol Inc.$2K
What the payments were for
- Travel & lodging$190%
- Food & beverage$2,61339%
- Education$4,00060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $4,910 |
| Davol Inc. | 10 | $618 |
| TELA Bio, Inc. | 2 | $303 |
| Virtual Incision Corporation | 1 | $154 |
| Johnson & Johnson | 3 | $84 |
| Mallinckrodt Enterprises LLC | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Medtronic | 1 | $51 |
| Axonics, Inc. | 2 | $50 |
| Integra Lifesciences Corporation | 2 | $44 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Kerecis Limited | 1 | $37 |
| Boston Scientific | 1 | $33 |
| AbbVie | 1 | $29 |
| Ferring Pharmaceuticals Inc. | 2 | $28 |
| Northgate Technologies, Inc. | 1 | $27 |
| Covidien LP | 1 | $26 |
| RTI Surgical, Inc | 1 | $20 |
| Cook Medical LLC | 1 | $18 |
| Smith+Nephew | 1 | $16 |
| Hollister Incorporated | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few colon & rectal surgery providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 11 | $1,785 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 90 | $1,326 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 13 | $836 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 25 | $385 |
| Neomycin Sulfate | 31 | $149 |
| Metronidazole | 38 | $59 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Omaha
- Alan ThorsonOmaha$24K
- Hernan HernandezOmaha$9K
- Austin PersonOmaha$6K
- Zachary TorgersenOmaha$3K
- Maniamparampil ShashidharanOmaha$915
- Jennifer LeinickeOmaha$563
- Jennifer BeatyOmaha$390
- Garnet BlatchfordOmaha$315
- Michael JobstLincoln$131K
- Kelly KrierLincoln$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.